Literature DB >> 19089337

Cyclic GMP-hydrolyzing phosphodiesterases.

Sharron H Francis1, Jackie D Corbin, Erwin Bischoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19089337     DOI： 10.1007/978-3-540-68964-5_16

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN： 0171-2004


× No keyword cloud information.
  13 in total

Review 1.  Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.

Authors:  Thérèse Keravis; Claire Lugnier
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Activation of PDE10 and PDE11 phosphodiesterases.

Authors:  Ronald Jäger; Corina Russwurm; Frank Schwede; Hans-Gottfried Genieser; Doris Koesling; Michael Russwurm
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

Review 3.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

4.  Structural basis of phosphodiesterase 6 inhibition by the C-terminal region of the gamma-subunit.

Authors:  Brandy Barren; Lokesh Gakhar; Hakim Muradov; Kimberly K Boyd; S Ramaswamy; Nikolai O Artemyev
Journal:  EMBO J       Date:  2009-10-01       Impact factor: 11.598

5.  Decreased catalytic activity and altered activation properties of PDE6C mutants associated with autosomal recessive achromatopsia.

Authors:  Tanja Grau; Nikolai O Artemyev; Thomas Rosenberg; Hélène Dollfus; Olav H Haugen; E Cumhur Sener; Bernhard Jurklies; Sten Andreasson; Christoph Kernstock; Michael Larsen; Eberhart Zrenner; Bernd Wissinger; Susanne Kohl
Journal:  Hum Mol Genet       Date:  2010-12-01       Impact factor: 6.150

6.  Determinants for phosphodiesterase 6 inhibition by its gamma-subunit.

Authors:  Zhongming Zhang; Nikolai O Artemyev
Journal:  Biochemistry       Date:  2010-05-11       Impact factor: 3.162

7.  Update on Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia.

Authors:  Dean S Elterman; Bilal Chughtai; Richard K Lee; Alexis E Te; Steven A Kaplan
Journal:  Rev Urol       Date:  2012

8.  Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II.

Authors:  Walid Mokni; Thérèse Keravis; Nelly Etienne-Selloum; Alison Walter; Modou O Kane; Valérie B Schini-Kerth; Claire Lugnier
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

Review 9.  Lipidomic mass spectrometry and its application in neuroscience.

Authors:  Mabel Enriquez-Algeciras; Sanjoy K Bhattacharya
Journal:  World J Biol Chem       Date:  2013-11-26

10.  Calcineurin regulates homologous desensitization of natriuretic peptide receptor-A and inhibits ANP-induced testosterone production in MA-10 cells.

Authors:  Michelle B Henesy; Andrea L Britain; Bing Zhu; Lauren Amable; Richard E Honkanen; Jackie D Corbin; Sharron H Francis; Thomas C Rich
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.